Tiny fatty (lipid) particles can be used to enhance the delivery of gene editing tools, such as CRISPR-Cas9, to…
Alice Melão
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Alice Melão
Treatment with EIP Pharma’s investigational therapy neflamapimod (VX-745) can restore nerve cells’…
Study Lauds Narrative Group Therapy as Alternative Strategy to Support Carriers of HTT Mutations
Narrative interventions can help provide support to individuals who are carriers of HTT gene mutations linked to Huntington’s…
RaDaR, the catchy new name for the U.S. government-run Rare Diseases Registry Program, aims to help patient advocacy groups…
A protein that can specifically bind to mutated forms of huntingtin and prevent its production — while preserving the normal…
Active psychiatric disorders are associated with increased risk of suicidal behaviors among Huntington’s patients participating in clinical trials, a large-scale study…
A software known as “DriveSafe DriveAware” can help evaluate if patients with Huntington’s disease still have the cognitive fitness…
Analysis of behavior patterns in genetically engineered mini pigs could be a valuable tool for assessing Huntington’s disease symptoms,…
tMMJ-002, a cannabis investigational product for the treatment of Huntington’s disease, has been granted Orphan Drug designation by the U.S.
A Phase 3 clinical trial is enrolling adults with Huntington’s disease across the United States and Canada to test the…